NCT02500836View on ClinicalTrials.gov

Topical Application of Cocaine HCl 4%, or 10%, or Placebo Solution in Local (Topical) Anesthesia

PHASE3CompletedINTERVENTIONAL
Enrollment

646

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

July 31, 2016

Study Completion Date

July 31, 2016

Conditions
Any Ear Nose or Throat ConditionsWith Identified Need for a Diagnostic Procedure or Surgery on or Through the Mucous Membranes of the Nasal Cavities
Interventions
DRUG

Cocaine HCl 4% Topical Solution

Topical solution, up to 4 mL, is applied for 20 minutes via cotton or rayon pledget(s) to the accessible mucous membranes of the nasal cavities.

DRUG

Cocaine HCl 10% Topical Solution

Topical solution, up to 4 mL, is applied for 20 minutes via cotton or rayon pledget(s) to the accessible mucous membranes of the nasal cavities.

DRUG

Placebo Topical Solution

Topical solution, up to 4 mL, is applied for 20 minutes via cotton or rayon pledget(s) to the accessible mucous membranes of the nasal cavities.

Trial Locations (1)

23235

Richmond ENT, Richmond

All Listed Sponsors
lead

Lannett Company, Inc.

INDUSTRY

NCT02500836 - Topical Application of Cocaine HCl 4%, or 10%, or Placebo Solution in Local (Topical) Anesthesia | Biotech Hunter | Biotech Hunter